NEA Management Company’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$1.17M Hold
2022
Q2
$3.99M Hold
2022
Q1
$8.77M Sell
2021
Q4
$17.3M Hold
2021
Q3
$20.7M Hold
2021
Q2
$24.7M Hold
2021
Q1
$23M Hold
2020
Q4
$22.3M Hold
2020
Q3
$23.3M Hold
2020
Q2
$30.6M Hold
2020
Q1
$22M Hold
2019
Q4
$40.6M Hold
2019
Q3
$27.7M Hold
2019
Q2
$87.2M Buy